SK149198A3 - Feline vaccines containing chlamydia psittaci and method for making the same - Google Patents

Feline vaccines containing chlamydia psittaci and method for making the same Download PDF

Info

Publication number: SK149198A3
Authority: SK; Slovakia
Prior art keywords: chlamydia psittaci; feline; vaccine; cats; cell line
Prior art date: 1996-05-06

Application number

SK1491-98A

Other languages

English (en)

Slovak (sk)

Inventor

Rebecca A Atherton

Norbert Schmeer

Jean A Hallstrom

Jennifer K Lane

Kristina J Hennessy

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-06

Filing date

1997-04-21

Publication date

2000-02-14

1997-04-21 Application filed by Bayer Ag filed Critical Bayer Ag

2000-02-14 Publication of SK149198A3 publication Critical patent/SK149198A3/sk

Links

241001647378 Chlamydia psittaci Species 0.000 title claims abstract description 67
229960005486 vaccine Drugs 0.000 title claims abstract description 59
241000282324 Felis Species 0.000 title claims abstract description 28
238000000034 method Methods 0.000 title claims description 20
241000282326 Felis catus Species 0.000 claims abstract description 53
239000000427 antigen Substances 0.000 claims description 21
108091007433 antigens Proteins 0.000 claims description 21
102000036639 antigens Human genes 0.000 claims description 21
239000002671 adjuvant Substances 0.000 claims description 20
239000000203 mixture Substances 0.000 claims description 12
241000700605 Viruses Species 0.000 claims description 10
238000011081 inoculation Methods 0.000 claims description 7
206010061041 Chlamydial infection Diseases 0.000 claims description 6
206010051497 Rhinotracheitis Diseases 0.000 claims description 6
229920001577 copolymer Polymers 0.000 claims description 6
239000012528 membrane Substances 0.000 claims description 6
241000867607 Chlorocebus sabaeus Species 0.000 claims description 5
229920002125 Sokalan® Polymers 0.000 claims description 5
239000000463 material Substances 0.000 claims description 5
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 4
201000000902 chlamydia Diseases 0.000 claims description 4
208000012538 chlamydia trachomatis infectious disease Diseases 0.000 claims description 4
238000003306 harvesting Methods 0.000 claims description 4
-1 mertiolate Chemical compound 0.000 claims description 4
229920000642 polymer Polymers 0.000 claims description 4
230000008569 process Effects 0.000 claims description 4
241000714165 Feline leukemia virus Species 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 3
230000009849 deactivation Effects 0.000 claims description 3
230000005847 immunogenicity Effects 0.000 claims description 3
230000000415 inactivating effect Effects 0.000 claims description 3
FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 claims description 2
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims description 2
241000713800 Feline immunodeficiency virus Species 0.000 claims description 2
102000014150 Interferons Human genes 0.000 claims description 2
108010050904 Interferons Proteins 0.000 claims description 2
102000015696 Interleukins Human genes 0.000 claims description 2
108010063738 Interleukins Proteins 0.000 claims description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 claims description 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 2
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 2
239000000839 emulsion Substances 0.000 claims description 2
230000008014 freezing Effects 0.000 claims description 2
238000007710 freezing Methods 0.000 claims description 2
239000002955 immunomodulating agent Substances 0.000 claims description 2
229940121354 immunomodulator Drugs 0.000 claims description 2
239000002799 interferon inducing agent Substances 0.000 claims description 2
229940047124 interferons Drugs 0.000 claims description 2
229940047122 interleukins Drugs 0.000 claims description 2
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 2
210000003097 mucus Anatomy 0.000 claims description 2
BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims description 2
239000004584 polyacrylic acid Substances 0.000 claims description 2
108090000765 processed proteins & peptides Proteins 0.000 claims description 2
102000004196 processed proteins & peptides Human genes 0.000 claims description 2
229960000380 propiolactone Drugs 0.000 claims description 2
239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
229930182490 saponin Natural products 0.000 claims description 2
150000007949 saponins Chemical class 0.000 claims description 2
239000011780 sodium chloride Substances 0.000 claims description 2
239000004094 surface-active agent Substances 0.000 claims description 2
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
229940033663 thimerosal Drugs 0.000 claims description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
239000005977 Ethylene Substances 0.000 claims 1
241000711475 Feline infectious peritonitis virus Species 0.000 claims 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims 1
241000711798 Rabies lyssavirus Species 0.000 claims 1
241000223997 Toxoplasma gondii Species 0.000 claims 1
239000003599 detergent Substances 0.000 claims 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical group P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 1
239000002953 phosphate buffered saline Substances 0.000 claims 1
201000010099 disease Diseases 0.000 abstract description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
241000606161 Chlamydia Species 0.000 abstract description 10
230000002265 prevention Effects 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 38
208000015181 infectious disease Diseases 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 10
238000002255 vaccination Methods 0.000 description 10
230000000890 antigenic effect Effects 0.000 description 7
239000012530 fluid Substances 0.000 description 7
238000009472 formulation Methods 0.000 description 7
239000002609 medium Substances 0.000 description 7
238000007918 intramuscular administration Methods 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000007920 subcutaneous administration Methods 0.000 description 6
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 5
210000004379 membrane Anatomy 0.000 description 5
244000005700 microbiome Species 0.000 description 5
239000008363 phosphate buffer Substances 0.000 description 5
241000714201 Feline calicivirus Species 0.000 description 4
229930193140 Neomycin Natural products 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
239000003937 drug carrier Substances 0.000 description 4
229960004927 neomycin Drugs 0.000 description 4
208000007190 Chlamydia Infections Diseases 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
235000013601 eggs Nutrition 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004044 response Effects 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
208000023514 Barrett esophagus Diseases 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
241000498849 Chlamydiales Species 0.000 description 2
206010011224 Cough Diseases 0.000 description 2
208000004729 Feline Leukemia Diseases 0.000 description 2
241000701915 Feline panleukopenia virus Species 0.000 description 2
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
206010024769 Local reaction Diseases 0.000 description 2
206010037151 Psittacosis Diseases 0.000 description 2
239000000872 buffer Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000007405 data analysis Methods 0.000 description 2
210000002969 egg yolk Anatomy 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
108010062490 p27 antigen Proteins 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
206010041232 sneezing Diseases 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
241000282465 Canis Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
208000009701 Embryo Loss Diseases 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
206010035742 Pneumonitis Diseases 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
206010058874 Viraemia Diseases 0.000 description 1
238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
210000000991 chicken egg Anatomy 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
210000000795 conjunctiva Anatomy 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
235000013345 egg yolk Nutrition 0.000 description 1
229920001038 ethylene copolymer Polymers 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
206010015915 eye discharge Diseases 0.000 description 1
229960004279 formaldehyde Drugs 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
229940031551 inactivated vaccine Drugs 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229940031346 monovalent vaccine Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
210000005000 reproductive tract Anatomy 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
238000012552 review Methods 0.000 description 1
210000004894 snout Anatomy 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000001018 virulence Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
210000001325 yolk sac Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SK1491-98A 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same SK149198A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/643,673 US5972350A (en)	1996-05-06	1996-05-06	Feline vaccines containing Chlamydia psittaci and method for making the same
PCT/US1997/007514 WO1997041889A1 (en)	1996-05-06	1997-04-21	Feline vaccines containing chlamydia psittaci and method for making the same

Publications (1)

Publication Number	Publication Date
SK149198A3 true SK149198A3 (en)	2000-02-14

Family

ID=24581818

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1491-98A SK149198A3 (en)	1996-05-06	1997-04-21	Feline vaccines containing chlamydia psittaci and method for making the same

Country Status (16)

Country	Link
US (1)	US5972350A (cs)
EP (1)	EP0904106A1 (cs)
JP (1)	JP2000510121A (cs)
AU (1)	AU717628B2 (cs)
BG (1)	BG63564B1 (cs)
BR (1)	BR9708975A (cs)
CA (1)	CA2203234A1 (cs)
CZ (1)	CZ297848B6 (cs)
EE (1)	EE04516B1 (cs)
IL (1)	IL126628A (cs)
NO (1)	NO320871B1 (cs)
NZ (1)	NZ332620A (cs)
PL (1)	PL329734A1 (cs)
SK (1)	SK149198A3 (cs)
TR (1)	TR199802259T2 (cs)
WO (1)	WO1997041889A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010048927A1 (en) *	2000-02-01	2001-12-06	Richard Stephens	Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US20030129161A1 (en) *	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
US7105171B2 (en) *	2002-03-07	2006-09-12	The Regents Of The University Of California	Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20050202046A1 (en) *	2004-03-11	2005-09-15	Wyeth	Canine vaccine for protection against ehrlichiosis
US7306807B2 (en)	2004-09-13	2007-12-11	Wyeth	Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CN100423775C (zh) *	2005-04-15	2008-10-08	中国农业科学院兰州兽医研究所	牛衣原体病灭活疫苗及其制备与检验方法
US20080299149A1 (en) *	2007-05-30	2008-12-04	Wyeth	Raccoon Poxvirus Expressing Genes of Feline Antigens
FR3039406B1 (fr)	2015-07-28	2020-09-18	Centre Nat Rech Scient	Composition vaccinale contre les infections a chlamydiaceae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5242686A (en) *	1990-11-07	1993-09-07	American Home Products Corporation	Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
CA2175081A1 (en) *	1993-11-03	1995-05-11	James Evan Sandbulte	Vaccine and method for treatment of chlamydial infections

1996
- 1996-05-06 US US08/643,673 patent/US5972350A/en not_active Expired - Fee Related
1997
- 1997-04-21 EP EP97924574A patent/EP0904106A1/en not_active Withdrawn
- 1997-04-21 CA CA002203234A patent/CA2203234A1/en not_active Abandoned
- 1997-04-21 IL IL12662897A patent/IL126628A/en not_active IP Right Cessation
- 1997-04-21 NZ NZ332620A patent/NZ332620A/xx unknown
- 1997-04-21 PL PL97329734A patent/PL329734A1/xx unknown
- 1997-04-21 EE EE9800388A patent/EE04516B1/xx not_active IP Right Cessation
- 1997-04-21 BR BR9708975A patent/BR9708975A/pt not_active Application Discontinuation
- 1997-04-21 WO PCT/US1997/007514 patent/WO1997041889A1/en not_active Ceased
- 1997-04-21 AU AU29962/97A patent/AU717628B2/en not_active Ceased
- 1997-04-21 TR TR1998/02259T patent/TR199802259T2/xx unknown
- 1997-04-21 JP JP09540090A patent/JP2000510121A/ja not_active Ceased
- 1997-04-21 SK SK1491-98A patent/SK149198A3/sk unknown
- 1997-04-21 CZ CZ0360498A patent/CZ297848B6/cs not_active IP Right Cessation
1998
- 1998-11-03 BG BG102890A patent/BG63564B1/bg unknown
- 1998-11-05 NO NO19985172A patent/NO320871B1/no unknown

Also Published As

Publication number	Publication date
CZ360498A3 (cs)	1999-03-17
JP2000510121A (ja)	2000-08-08
TR199802259T2 (xx)	1999-02-22
PL329734A1 (en)	1999-04-12
CA2203234A1 (en)	1997-11-06
WO1997041889A1 (en)	1997-11-13
AU717628B2 (en)	2000-03-30
EE9800388A (et)	1999-06-15
CZ297848B6 (cs)	2007-04-11
NZ332620A (en)	2000-04-28
NO320871B1 (no)	2006-02-06
EE04516B1 (et)	2005-08-15
IL126628A0 (en)	1999-08-17
AU2996297A (en)	1997-11-26
BR9708975A (pt)	1999-08-03
NO985172L (no)	1999-01-06
BG63564B1 (bg)	2002-05-31
US5972350A (en)	1999-10-26
NO985172D0 (no)	1998-11-05
EP0904106A1 (en)	1999-03-31
MX9703278A (es)	1998-05-31
IL126628A (en)	2002-09-12
BG102890A (en)	1999-09-30

Publication	Publication Date	Title
McClurkin et al.	1985	Isolation of cytopathic and noncytopathic bovine viral diarrhea virus from the spleen of cattle acutely and chronically affected with bovine viral diarrhea
CN1268393C (zh)	2006-08-09	经改良修饰的brsv或疫苗
EP0329264B1 (en)	1994-03-23	Veterinary vaccines
US5242686A (en)	1993-09-07	Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6951650B1 (en)	2005-10-04	Antigenic class of avian reoviruses
SK149198A3 (en)	2000-02-14	Feline vaccines containing chlamydia psittaci and method for making the same
KR100302522B1 (ko)	2001-11-30	고양이장코로나바이러스로부터의개코로나바이러스왁찐
US6004563A (en)	1999-12-21	Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US7211260B1 (en)	2007-05-01	Infectious bursitis vaccine
KR100556275B1 (ko)	2007-03-02	클라미디아시타시를함유하는고양이백신및그의제조방법
US20020146425A1 (en)	2002-10-10	Feline vaccines containing chlamydia psittaci and method for making the same
MXPA97003278A (es)	1998-10-23	Vacunas felinas que contienen chlamydia psittaci y metodo para preparar las mismas
HK1021334A (en)	2000-06-09	Feline vaccines containing chlamydia psittaci and method for making the same
CN1223589A (zh)	1999-07-21	包含鹦鹉热衣原体的猫疫苗及其制备方法
HUP9902924A2 (hu)	2000-01-28	Chlamydia psittaci-t tartalmazó macskaoltó anyagok és eljárás előállításukra
AU3441693A (en)	1993-08-03	Feline leukemia virus vaccines
FR2601251A1 (fr)	1988-01-15	Agent viral non pathogene pour la prevention de la gastroenterite transmissible porcine, son obtention et son utilisation comme vaccin.
MXPA99007134A (en)	2000-05-01	Infectious bursitis vaccine